- Home
- BOH vs IMVT Comparison
BOH vs IMVT Comparison
Compare BOH & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOH
- IMVT
- Stock Information
- Founded
- BOH 1897
- IMVT N/A
- Country
- BOH United States
- IMVT United States
- Employees
- BOH N/A
- IMVT N/A
- Industry
- BOH Major Banks
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOH Finance
- IMVT Health Care
- Exchange
- BOH Nasdaq
- IMVT Nasdaq
- Market Cap
- BOH 2.8B
- IMVT 2.5B
- IPO Year
- BOH N/A
- IMVT N/A
- Fundamental
- Price
- BOH $65.93
- IMVT $14.89
- Analyst Decision
- BOH Hold
- IMVT Buy
- Analyst Count
- BOH 6
- IMVT 10
- Target Price
- BOH $73.17
- IMVT $40.14
- AVG Volume (30 Days)
- BOH 332.5K
- IMVT 1.2M
- Earning Date
- BOH 07-21-2025
- IMVT 05-29-2025
- Dividend Yield
- BOH 4.21%
- IMVT N/A
- EPS Growth
- BOH N/A
- IMVT N/A
- EPS
- BOH 3.56
- IMVT N/A
- Revenue
- BOH $640,351,000.00
- IMVT N/A
- Revenue This Year
- BOH $15.16
- IMVT $108.88
- Revenue Next Year
- BOH $7.83
- IMVT N/A
- P/E Ratio
- BOH $18.68
- IMVT N/A
- Revenue Growth
- BOH N/A
- IMVT N/A
- 52 Week Low
- BOH $54.98
- IMVT $12.72
- 52 Week High
- BOH $82.70
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- BOH 42.59
- IMVT 50.82
- Support Level
- BOH $66.11
- IMVT $13.79
- Resistance Level
- BOH $68.22
- IMVT $15.22
- Average True Range (ATR)
- BOH 1.21
- IMVT 0.69
- MACD
- BOH -0.40
- IMVT 0.14
- Stochastic Oscillator
- BOH 6.55
- IMVT 75.00
About BOH Bank of Hawaii Corporation
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).